This site is intended for health professionals only
Wednesday 20 September 2017
Share |

Roche launches CoaguChek Pro II system to determine coagulation status of patients at all points of care

Roche announced that it has launched the CoaguChek Pro II system in countries accepting the CE Mark.1 CoaguChek Pro II combines two tests in a single device – the activated partial thromboplastin time (aPTT) test and the prothrombin time (PT) test with extended claims – for greater insight into patients’ coagulation status in acute care settings, such as emergency rooms, operating rooms and intensive care units, or anticoagulation clinics.

Ads by Google